🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a phase II trial using a non-myeloablative cyclophosphamide/ fludar...
Status
Completed
Location
Masonic Cancer Center at University of Minnesota
Start Date
2017-03-09
Trial ID
NCT02661035
This phase I/II trial studies the side effects of fludarabine phosphate, cy...
Status
Terminated
Location
The Children's Hospital at TriStar Centennial
Start Date
2006-05-24
Trial ID
NCT00358657
Allogeneic transplantation is used to treat many malignant and non-malignan...
Status
Completed
Location
Duke University Health System
Start Date
2013-08
Trial ID
NCT01904175
In the transplant community, there is debate regarding the most appropriate...
Status
Completed
Location
Duke University Medical Center
Start Date
2009-04
Trial ID
NCT01687231
Treatments Being Tested
This phase II trial studies how well total-body irradiation (TBI) works whe...
Status
Completed
Location
Children's Hospital and Research Center at Oakland
Start Date
2007-02
Trial ID
NCT00453388
Chronic GVHD (cGVHD) is a predominant cause of mortality and disability not...
Status
Unknown
Location
Hospital Universitario de la U.A.N.L.
Start Date
2023-08-01
Trial ID
NCT06348602
Treatments Being Tested
Primary Objective: 1\. To determine the maximally tolerated dose of anti-t...
Status
Terminated
Location
U.T.M.D. Anderson Cancer Center
Start Date
2007-05
Trial ID
NCT00473551
The study is designed as a Phase III, multi-center trial of tandem autologo...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2003-12
Trial ID
NCT00075829
Relapse remains a principle cause of treatment failure for patients with ag...
Status
Completed
Location
Massachusetts General Hospital
Start Date
2010-08
Trial ID
NCT01181271
Treatments Being Tested
Although transplant results for AML in complete remission (CR) at the time ...
Status
Completed
Location
University of Alabama, Birmingham
Start Date
2011-11
Trial ID
NCT01457885
Treatments Being Tested